OrbiMed was advised by LPA-CGR, BCLP, and Covington & Burling. Dechert LLP (Paris and New York) advised Poxel. OrbiMed announced it has entered into a non-dilutive...
You must be a Standard 1 Year member to access this content.
Covington & Burling advised Omeros Corporation on the deal, and King & Spalding and Paul Hastings represented the lenders. Omeros Corporation (Omeros) (Nasdaq: OMER) announced it...
You must be a Standard 1 Year member to access this content.
Covington & Burling represented OrbiMed Advisors, LLC in the transaction. OrbiMed Advisors, LLC, a healthcare investment firm, announced a debt financing facility for up to $50...
You must be a Standard 1 Year member to access this content.
Covington & Burling and Brunini, Grantham, Grower & Hewes advised Trustmark National Bank on the transaction. Marsh McLennan Agency, a subsidiary of Marsh, announced that it...
You must be a Standard 1 Year member to access this content.
Covington & Burling represented MidFirst Bank, and Squire Patton Boggs represented Amerant Bancorp Inc. Amerant Bancorp Inc. (NYSE: AMTB) (“Amerant” or the “Company”) announced that its...
You must be a Standard 1 Year member to access this content.
Covington & Burling LLP represented Catalio Capital Management, LP in the deal. TapestryHealth announced $25 million credit investment from Catalio Capital Management (“Catalio”). The term loan is an...
You must be a Standard 1 Year member to access this content.
Covington & Burling advised OrbiMed on the deal. OrbiMed announced its $125 million debt financing with Verrica Pharmaceuticals, a dermatology therapeutics company developing medications for skin diseases...
You must be a Standard 1 Year member to access this content.
Covington & Burling advised Atlantic Union Bankshares Corporation and Williams Mullen advised American National Bankshares Inc. on the transaction. Atlantic Union Bankshares Corporation announced it has...
You must be a Standard 1 Year member to access this content.
Covington advised Humacyte on the deal. Humacyte, Inc. announced its $150 million revenue-based funding arrangement, as well as a $10 million equity investment option, with Oberland...
You must be a Standard 1 Year member to access this content.
Covington advised OrbiMed on the deal. An investment fund affiliated with OrbiMed Advisors announced a $75 million delayed draw senior secured loan to be provided to...
You must be a Standard 1 Year member to access this content.
Covington advised OrbiMed on the deal. OrbiMed acted as the lead investor in a $400 million senior secured term loan facility provided to Caris Life Sciences, a...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Roivant Sciences Ltd. in the deal, while Covington represented the underwriter, Cantor Fitzgerald. Roivant Sciences Ltd. announced its debut SEC-registered offering of 30,000,000...
You must be a Standard 1 Year member to access this content.
